Skip to main content

Mark Lewis


Napro Research

Dr. Mark Lewis founded NaPro Research in 2011, a company dedicated to creating analytical solutions and products across four sectors: biotechnology, production, laboratory services and consumer education. His latest publication, Pharmacological Foundations of Cannabis Chemovars, co-authored with Dr. Ethan Russo, explores potential applications of cannabis hybrid plants – chemovars – that vary only in cannabinoid ratio. The plants have been used to investigate the different effects associated with varying ratios of cannabinoids and to study CBD as a buffer to protect against the harm caused by chronic THC use without the loss of sensory appeal. Additionally, his decades of research focused on plant breeding and crop production optimization paid off at the 2017 Emerald Cup when Molecular Farms,  a client of Napro Research, won the overall flower category and the top CBD flower at the competition.


Dr. Lewis earned a B.S. in Chemical Engineering from the Rose-Hulman Institute of Technology and received his Ph.D. in Chemistry at Purdue University. He is a member of International Cannabinoid Research Society (ICRS) and American Chemical Society (ACS).

Product Type
On Demand

Genetics & Bioscience

Average Rating:
Not yet rated
Intellectual Property |  Advertising, Packaging and Labeling |  Copyrights and Trademarks |  Patents & Trade Secrets |  Licensing
Marcelo Pomeranz |  Travis Bliss |  Pauline Pelletier |  Mark Lewis
1 Hour 4 Minutes
Audio and Video
Access for 6 month(s) after purchase.
Short Description:
Join us for a discussion of patents, patent rights, limitations of patents, and alternatives for protection, from utility to Plant Patents and PVP. Additionally, the panel will delve into deposit requ...
$75.00 - Non Member Price

Showing 1 to 1 of 1 entries